A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2004
10/13/2004	EP1465925A2 Antibodies that immunospecifically bind to trail receptors
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465916A2 Novel g proein-coupled receptor, gave7
10/13/2004	EP1465911A2 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
10/13/2004	EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins
10/13/2004	EP1465896A2 Mitotic kinesin inhibitors
10/13/2004	EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004	EP1465871A1 Pyrazole derivatives for use in diseases associated with the 5-ht2c receptor
10/13/2004	EP1465868A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression
10/13/2004	EP1465866A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/13/2004	EP1465863A1 Potassium channel modulators
10/13/2004	EP1465667A2 Screening and selection methods for statin drug combinations
10/13/2004	EP1465662A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound
10/13/2004	EP1465661A1 Cancer treatment
10/13/2004	EP1465650A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
10/13/2004	EP1465645A1 A novel herbal chemical composition for the treatment of cancer
10/13/2004	EP1465642A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
10/13/2004	EP1465638A2 Phosphate transport inhibitors
10/13/2004	EP1465637A1 25-hydroxy vitamin d3 compositions
10/13/2004	EP1465634A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
10/13/2004	EP1465633A1 Quinazolinone compounds in combined modalities for improved cancer treatment
10/13/2004	EP1465632A1 Quinazoline derivatives for the treatment of abnormal cell growth
10/13/2004	EP1465629A1 5-ht3 receptor antagonists and methods of use
10/13/2004	EP1465627A1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS
10/13/2004	EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
10/13/2004	EP1465624A1 Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof
10/13/2004	EP1465622A1 Use of ppar activators for the treatment of pulmonary fibrosis
10/13/2004	EP1465621A2 Compositions and methods of treatment involving peroxisome proliferator activated receptor gamma agonists and cyclooxygenase 2 selective inhibitors
10/13/2004	EP1465614A2 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
10/13/2004	EP1465613A2 Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs
10/13/2004	EP1465610A1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
10/13/2004	EP1465609A2 Modulation of dopaminergic neurons
10/13/2004	EP1465606A2 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
10/13/2004	EP1465596A1 Polymeric gel system for the controlled delivery of codrugs
10/13/2004	EP1465591A1 Antibiotic product, use and formulation thereof
10/13/2004	EP1465563A1 METHOD OF SYSTEMICALLY DELIVERING SSRIs
10/13/2004	EP1465521A2 System and method for the pretreatment of the endplates of an intervertebral disc
10/13/2004	EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004	EP1361897A4 Methods for inhibiting pain
10/13/2004	EP1347987B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/13/2004	EP1286682A4 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
10/13/2004	EP1207840B1 Pharmaceutical compositions and methods for reducing the appearance of cellulite
10/13/2004	EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004	EP1165069B1 Antitumour synergistic composition
10/13/2004	EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction
10/13/2004	EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors
10/13/2004	EP1107745B1 Use of 5ht-6 antagonists for the treatment of adhd
10/13/2004	EP0973818B1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/13/2004	EP0873136B1 High fluorescence specific immune enhancing factor and methods of use for same
10/13/2004	EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
10/13/2004	EP0637933B1 Method for treating organs and tissues
10/13/2004	EP0542988B1 Improved euthanasia compositions
10/13/2004	CN1537167A Von willebrand factor (VWF)-cleaving enzyme
10/13/2004	CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
10/13/2004	CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
10/13/2004	CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor
10/13/2004	CN1537017A Remedie for inflammatory bowel diseases
10/13/2004	CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases
10/13/2004	CN1537006A Drug combination for treatment of headache comprising mirtazapine and paracetamol or non-steroidal anti-inflammatory drug
10/13/2004	CN1537004A Compositions containing imidazotriazinone for nasal application
10/13/2004	CN1536998A Integrin inhibitors for treatment of eye diseases
10/13/2004	CN1536995A Antitumor compositions containing taxane derivatives
10/13/2004	CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum
10/13/2004	CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health
10/13/2004	CN1536988A Sustained-release delivery system
10/13/2004	CN1535729A Tumor gene vaccine based on ectopic chorionic gonadotropin beta and its preparation method
10/13/2004	CN1535727A Mixed polypeptide vaccine, its preparation and application
10/13/2004	CN1535692A Nitrogen oxide for curing inplammation
10/13/2004	CN1535688A Combined preparation containing morpholine anthracene nucleus compound and autcancer preparation
10/13/2004	CN1535682A Medicine for improved bladder excretion capacity
10/13/2004	CN1535681A Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal
10/13/2004	CN1170931C Vasculogenesis correlation molecule
10/13/2004	CN1170849C Connective tissue growth factor fragments and methods and uses thereof
10/13/2004	CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid
10/13/2004	CN1170534C Pharmaceutical compositions containing lipase inhibitors
10/13/2004	CN1170528C Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites
10/12/2004	US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/12/2004	US6803379 Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
10/12/2004	US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc
10/12/2004	US6803361 Administering nucleotide sequence
10/12/2004	US6803357 Inhibitors of dipeptidylpeptidase iv (dpiv) sufficient to treat type ii diabetes but not sufficient to suppress the immune system
10/12/2004	US6803211 Cancer therapy
10/12/2004	US6803189 Methods for the detection of cervical cancer
10/12/2004	US6803060 Composition to boost libido
10/12/2004	US6803058 Boric acid and sublimed sulfur; nonallerginic; deodorizing; preventing perspiration; low cost, simple
10/12/2004	US6803052 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
10/12/2004	US6803041 Chemically inactivated ehv-1 kya virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer.
10/12/2004	US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM
10/12/2004	US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil.
10/07/2004	WO2004085418A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
10/07/2004	WO2004084945A1 Eating controllers
10/07/2004	WO2004084927A2 Compositions for inducing of immunotolerance
10/07/2004	WO2004084905A2 Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
10/07/2004	WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004	WO2004084897A1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
10/07/2004	WO2004084896A1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
10/07/2004	WO2004084894A1 Synergistic combination comprising roflumilast and revatropate for the treatment of respiratory diseases
10/07/2004	WO2004084881A1 METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
10/07/2004	WO2004084880A1 METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
10/07/2004	WO2004084879A1 Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators

1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1151